qfx

But let’s play the “What If” game, Wall Street’s favorite parlor trick. What if you’d thrown $10,000 into Tesla three years ago? Strap in, Dorothy-it’s a tornado of numbers ahead.

But let’s not blame the REITs. They’re not slacking-they’re just stuck in 2015, wearing last year’s fashion trends while the S&P 500 struts in like it owns the place. The problem? Two things: megacap tech stocks, which have turned into financial influencers with 10 million followers, and interest rates, which have been playing a cruel game of emotional whack-a-mole.

In the late 1990s, Nvidia’s GPUs were the darlings of the gaming community, much like a well-tailored waistcoat in a world of rumpled shirts. Yet, under the stewardship of Jensen Huang, the company saw beyond the confines of video games, recognizing the latent potential of parallel processing chips. Fast forward to today, and these chips have become the backbone of AI, much like a well-stocked larder is to a banquet.

Prosper Junior Bakiny (Abbott Laboratories): Abbott Laboratories, that titan of diagnostics and devices, walks a tightrope between tariffs and triumph. Its four wings-medical devices, pharmaceuticals, diagnostics, and nutrition-form a cathedral of diversification. Each segment, a vault guarding against the tremors of misfortune. The FreeStyle Libre, its most luminous gem, glows with uncharted territory in the diabetes realm. Yet, what is innovation but a recursive loop, a mirror reflecting newer iterations of itself?

Unity Software (U) used to be the champagne of the gaming world. Now it’s swilling cheap bourbon. The stock’s down 81% from its high – looks like a corpse in a morgue drawer. But corpses sometimes twitch when the right lightning hits. Enter Matt Bromberg, the new sheriff in town. His “inflection point” chatter? That’s the kind of line a con man feeds you before the lights go out. Except this time, the lights might just flicker back on.

Even with its dividend payouts-like a miser sprinkling pennies at a feast-Camden’s total return has trailed the S&P 500 like a hound dog after a rabbit. Now, I ain’t sayin’ this makes CPT a diamond in the rough, but it sure smells like someone spilled a whole jar of “undervalued” on the stock ticker. Let’s see if the scent lingers.

Let us speak of quantum computing, that odd offspring of mechanics and uncertainty, capable of solving problems so devious they would make even the mightiest classical computer tremble in terror. These promises of unfathomable power are not the musings of a madman, no, they are real, and within them lies the potential to make fortunes-for those who know where to look. So, allow me to offer, with utmost seriousness (though a smile might slip through), three stocks poised to benefit from the coming quantum flood in 2025, presented not in any order of importance, but alphabetically, for reasons you may soon understand.

In a world where the very concept of progress dissolves into abstraction, IBM persists as a monument to paradoxical survival, its revenue projections-modest 5% growth-haunted by the specter of last year’s stagnation. The company’s migration toward high-margin software, that most ephemeral of commodities, has conjured $13.5 billion in annual free cash flow, a number as real and unreal as the shifting sands of a desert that only pretends to be arid. Clients, desperate yet skeptical, funnel $7.5 billion into generative AI initiatives whose value remains locked in a vault labeled “Consulting,” while Red Hat’s hybrid cloud revenues swell like a tumor with a double-digit growth rate. The machinery grinds on.